ClinicalTrials.Veeva

Menu

Evaluation of a Training for Healthcare Providers in Supporting Men Experiencing Suicidal Ideation

U

University Ghent

Status

Enrolling

Conditions

Suicidal Ideation
Suicide

Treatments

Behavioral: Gatekeeper training (e-learning)

Study type

Interventional

Funder types

Other

Identifiers

NCT06810713
ONZ-2024-0536

Details and patient eligibility

About

The primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed.

Full description

In a previous study (BUN: B6702024000090), the authors focused on identifying barriers and needs among adult men experiencing suicidal thoughts and their healthcare providers. Findings from this needs assessment indicate a demand for a training (e-learning) to equip healthcare providers with strategies for working effectively with men experiencing suicidal ideation. Additionally, the assessment among individuals with suicidal ideation identified several key recommendations and considerations which healthcare providers should incorporate into their practice. Therefore, an e-learning was developed with integrated psycho-education and the primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed.

Participants will be recruited through announcements on the Flemish suicide prevention portal website (www.zelfmoord1813.be) and websites of relevant partners (i.e. VVKP, VVP, Gezond Leven, Psyché, Vivel, Logo's, CGG-SP, Domus Medica,...), as well as via social media (mainly Linkedin, Instagram and Facebook) and newsletters of the Flemish Centre of Expertise in Suicide Prevention and its relevant partner organizations.

Individuals interested in participating will be directed to register online through REDCap, where they will review and approve an informed consent form.After providing informed consent, participants will be asked to provide their email address.

The email address will be used solely for the following purposes:

  • Sending a reminder to complete the post-test questionnaire three days later. Once consent is provided, participants will be directed to the online pre-test questionnaire (see Table 1), which takes approximately 10 minutes to complete. Following the pre-test, participants will be directed to the e-learning module, which requires 30-60 minutes. At the end of the e-learning, healthcare providers will be asked to complete the post-test questionnaire, which is estimated to take 15 minutes. In case a participant does not complete the post-test, a reminder will be sent via e-mail three days later.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthcare providers (e.g. GP's, psychiatrists, medical doctors, psychologists, psychotherapists, and nurses working in healthcare)
  • ≥18y/o
  • Access to a smartphone, tablet, or computer with internet connection and proficiency in Dutch

Exclusion criteria

  • Does not meet the specified inclusion criteria.

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 1 patient group

Gatekeeper training (e-learning)
Experimental group
Description:
Participants in this group (all participants) are asked to complete a questionnaire and then receive access to the online training (e-learning), after which they were asked to complete another questionnaire. In case a participant does not complete the post-test, a reminder will be sent via e-mail three days later.
Treatment:
Behavioral: Gatekeeper training (e-learning)

Trial contacts and locations

1

Loading...

Central trial contact

Eva De Jaegere, PhD; Pauline Stas, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems